As a MNTA investor, I want to know as much as possible about Copaxone. Moreover, I follow all of the major players in generic drugs, so I never miss a Teva CC.
What I no longer strongly care about is Teva’s Lovenox program (#msg-78098392).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.